Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cryo-Cell International, Inc. (CCEL)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
6.65+0.06 (+0.97%)
At close: 03:01PM EDT
6.51 -0.14 (-2.11%)
After hours: 04:35PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/25/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 314.00
52 Week Low 35.00
50-Day Moving Average 36.21
200-Day Moving Average 37.73

Share Statistics

Avg Vol (3 month) 36.22k
Avg Vol (10 day) 36.39k
Shares Outstanding 58.53M
Implied Shares Outstanding 6N/A
Float 83.73M
% Held by Insiders 151.09%
% Held by Institutions 19.62%
Shares Short (Jul 14, 2022) 49.4k
Short Ratio (Jul 14, 2022) 42.06
Short % of Float (Jul 14, 2022) 40.17%
Short % of Shares Outstanding (Jul 14, 2022) 40.11%
Shares Short (prior month Jun 14, 2022) 46.02k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 08, 2022
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 29, 2021
Most Recent Quarter (mrq)May 30, 2022

Profitability

Profit Margin 5.68%
Operating Margin (ttm)9.36%

Management Effectiveness

Return on Assets (ttm)3.06%
Return on Equity (ttm)40.10%

Income Statement

Revenue (ttm)29.71M
Revenue Per Share (ttm)3.50
Quarterly Revenue Growth (yoy)5.90%
Gross Profit (ttm)18.73M
EBITDA 4.19M
Net Income Avi to Common (ttm)1.69M
Diluted EPS (ttm)0.45
Quarterly Earnings Growth (yoy)-45.80%

Balance Sheet

Total Cash (mrq)2.87M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)1.13M
Total Debt/Equity (mrq)25.57
Current Ratio (mrq)0.66
Book Value Per Share (mrq)-0.22

Cash Flow Statement

Operating Cash Flow (ttm)7.18M
Levered Free Cash Flow (ttm)-7.19M
Advertisement
Advertisement